In a current research, we reported the identification and the characterization of a brand new atypical opioid receptor with distinctive detrimental regulatory Attributes toward opioid peptides.1 Our benefits confirmed that ACKR3/CXCR7, hitherto called an atypical scavenger receptor for chemokine